FdaApplication
ANDA 203621
Identifiers
- fda_app_no: ANDA203621
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMACEUTICAL ASSOCIATES INC |
| application_type | ANDA |
| approval_date | 2016-01-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NYSTATIN | NYSTATIN | 100,000 UNITS/ML | SUSPENSION;ORAL |
1 product